EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Lock out: targeting TMPRSS2 to block influenza and coronaviruses

Lu Zhang iD, Markus Hoffmann iD, Stefan Pöhlmann iD

Journal of Virology · 23.06.2026 · 100 (6)

DOI: 10.1128/jvi.00807-25 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Virology, erschienen am 23.06.2026. Verfasst von Lu Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Infection Biology Unit, German Primate Center - Leibniz Institute for Primate Research, Göttingen, Germany. Hauptthemen laut MEDLINE: Serine Endopeptidases, Influenza, Human, Influenza A virus, Antiviral Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 164 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: HORIZON EUROPE Health, Niedersächsisches Ministerium für Wissenschaft und Kultur, German Center for Infection Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Coronaviruses and influenza A viruses (IAV) can cause severe respiratory disease and have pandemic potential. Both viruses depend on priming of their glycoproteins by host cell proteases for the acquisition of infectivity, and the responsible enzymes represent potential targets for intervention. Initial studies suggested that these viruses may exploit redundant proteolytic systems. However, research conducted over the last two decades has pointed to a key role for a single enzyme in coronavirus and IAV priming, the transmembrane protease serine 2 (TMPRSS2). Interest in TMPRSS2 as a host dependency factor and therapeutic target intensified during the COVID-19 pandemic, prompting extensive investigation into its biology, substrate specificity, and pharmacological inhibition. Here, we review recent efforts to define the role of TMPRSS2 in coronavirus infection and to target this protease for antiviral intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Serine EndopeptidasesInfluenza, HumanInfluenza A virusAntiviral AgentsHumansSARS-CoV-2COVID-19AnimalsPandemicsSpike Glycoprotein, Coronavirus

Stichwörter der Autor:innen

SARS-CoV-2TMPRSS2primingproteasespike

Substanzen

Serine EndopeptidasesTMPRSS2 protein, humanAntiviral AgentsSpike Glycoprotein, Coronavirus

Autor:innen und Institutionen

  • Infection Biology Unit, German Primate Center - Leibniz Institute for Primate Research, Göttingen, Germany.
  • Faculty of Biology and Psychology, Georg-August-University Göttingen, Göttingen, Germany.

ORCID-Profile: Lu Zhang, Markus Hoffmann, Stefan Pöhlmann

Förderung

  • HORIZON EUROPE Health
  • Niedersächsisches Ministerium für Wissenschaft und Kultur
  • German Center for Infection Research

Zitieren

APA

Zhang, L., Hoffmann, M., & Pöhlmann, S. (2026). Lock out: targeting TMPRSS2 to block influenza and coronaviruses. Journal of Virology, 100(6). https://doi.org/10.1128/jvi.00807-25

Vancouver

Zhang L, Hoffmann M, Pöhlmann S. Lock out: targeting TMPRSS2 to block influenza and coronaviruses. Journal of Virology. 2026;100(6). doi:10.1128/jvi.00807-25

BibTeX
@article{Zhang2026,
  author = {Zhang, Lu and Hoffmann, Markus and Pöhlmann, Stefan},
  title = {Lock out: targeting TMPRSS2 to block influenza and coronaviruses},
  journal = {Journal of Virology},
  year = {2026},
  volume = {100},
  number = {6},
  doi = {10.1128/jvi.00807-25}
}
Kostenlos starten →